CGBD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Carlyle Secured Lending Inc (CGBD) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near flat with mixed technical momentum, analysts are leaning cautious despite a few bullish calls, and latest financials show revenue growth but weaker earnings and EPS. For an impatient investor who does not want to wait for a better entry, this is still more of a hold than an immediate buy.
The chart setup is neutral. MACD histogram is slightly positive at 0.0252 but contracting, which suggests upside momentum is fading. RSI_6 at 50.103 is neutral, showing no clear overbought or oversold condition. Moving averages are converging, indicating consolidation rather than a confirmed uptrend. Price at 11.81 is just above pivot support at 11.709, with resistance at 12.097 and 12.337. Short-term trend signals are modestly positive, but not strong enough to justify a decisive buy.
["Revenue in 2025/Q4 increased 14.44% YoY, showing top-line growth.", "Option positioning is heavily skewed toward calls, which suggests bullish sentiment.", "B. Riley upgraded the stock to Buy with a $13 target, citing attractive yield and limited downside.", "Wells Fargo still sees it as a favored discounted play near term despite lowering target."]
["Net income fell 15.12% YoY and EPS dropped 33.33% YoY in the latest quarter.", "JPMorgan and BofA both cut price targets recently, reflecting more cautious sentiment.", "No recent news catalyst in the past week.", "No significant hedge fund or insider buying trends were identified.", "No recent congress trading data and no notable influential figure activity."]
In 2025/Q4, Carlyle Secured Lending posted revenue of 60.27 million, up 14.44% YoY, which is positive for growth. However, profitability weakened: net income declined 15.12% YoY to 17.39 million and EPS fell 33.33% YoY to 0.24. Gross margin also slipped slightly to 97.92. Overall, the latest quarter shows sales growth but weaker bottom-line performance.
Analyst sentiment is mixed to cautious. Recent target cuts from JPMorgan ($12 to $10, Neutral) and BofA ($12 to $11, Underperform) show downward revisions. Offsetting that, Wells Fargo kept Overweight with a lowered target of $13, and B. Riley upgraded the stock to Buy with a $13 target. Net view from Wall Street is divided: some pros like the valuation and dividend yield, while others are concerned about reduced multiples and higher scrutiny in the BDC space.
